General
Preferred name
CLORAZEPIC ACID
Synonyms
clorazepate ()
CLORAZEPATE DIPOTASSIUM ()
CLORAZEPATE MONOPOTASSIUM ()
ABBOTT-35616 FREE ACID ()
Clorazepate ()
4306-CB FREE ACID ()
Chlorazepate ()
4311 CB ()
Clorazepic acid monopotassium salt ()
ABBOTT-39083 ()
Clorazepate potassium ()
Potassium Clorazepate ()
4311-CB ()
P&D ID
PD009881
CAS
20432-69-3
23887-31-2
5991-71-9
57109-90-7
Tags
available
drug candidate
drug
Approved by
FDA
First approval
1972
Drug indication
Anxiety disorder
Anxiety
Drug Status
approved
withdrawn
illicit
Max Phase
4.0
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
The marketed formulation is a racemic mixture of stereo-isomers; R-clorazepate and S-clorazepate. We show the non-isomeric molecule to represent this mixture.
(GtoPdb)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
13
ChEMBL Approved Drugs
ChEMBL Drugs
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
DrugMatrix
Guide to Pharmacology
NCATS Inxight Approved Drugs
ReFrame library
Withdrawn 2.0
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
45
Molecular Weight
314.05
Hydrogen Bond Acceptors
3
Hydrogen Bond Donors
2
Rotatable Bonds
2
Ring Count
3
Aromatic Ring Count
2
cLogP
2.58
TPSA
78.76
Fraction CSP3
0.06
Chiral centers
1.0
Largest ring
7.0
QED
0.84
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
ATC
N05BA05
Toxicity type
multiple
Therapeutic Class
Hypnotics and Sedatives
Source data

